ArticleGlycobiology2024

CD301 and LSECtin glycan-binding receptors of innate immune cells serve as prognostic markers and potential predictors of immune response in breast cancer subtypes.

Anne-Sophie Wegscheider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.